Cargando…
TREM2 Agonism with a Monoclonal Antibody Attenuates Tau Pathology and Neurodegeneration
TREM2 is a membrane receptor expressed on microglia that plays a pivotal role in the organization and function of these innate immune cell components within the neurodegenerated brain. Whereas TREM2 deletion has been studied extensively in experimental beta-amyloid and Tau-based models of Alzheimer’...
Autores principales: | Fassler, Michael, Benaim, Clara, George, Jacob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252191/ https://www.ncbi.nlm.nih.gov/pubmed/37296669 http://dx.doi.org/10.3390/cells12111549 |
Ejemplares similares
-
Engagement of TREM2 by a novel monoclonal antibody induces activation of microglia and improves cognitive function in Alzheimer’s disease models
por: Fassler, Michael, et al.
Publicado: (2021) -
Dual Targeting of Soluble Oligomeric and Aggregated Transthyretin with a Monoclonal Antibody Ameliorates Experimental Neuropathy
por: Fassler, Michael, et al.
Publicado: (2022) -
Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology
por: Suárez-Calvet, Marc, et al.
Publicado: (2019) -
sTREM2 is associated with attenuated tau aggregate accumulation in the presence of amyloid-β pathology
por: Nabizadeh, Fardin
Publicado: (2023) -
A Single Chain Fragment Variant Binding Misfolded Alpha-Synuclein Exhibits Neuroprotective and Antigen-Specific Anti-Inflammatory Properties
por: Fassler, Michael, et al.
Publicado: (2022)